Marijuana Rescheduling Update The Drug Report

Kevin Sabet joins the conversation, bringing a laser-sharp focus to the seismic shifts that may redefine the cannabis landscape. Prepare to arm yourself with knowledge as we dissect the implications of potentially reclassifying marijuana from a Schedule 1 to Schedule 3 substance, an issue that's got stakeholders from Wall Street to Main Street perched on the edge of their seats. As rumors of an imminent decision swirl, we cut through the haze to analyze what this monumental move would mean.Fo...